Abellio London Bus, one of London’s most innovative public transport companies, has become the first bus operator to adopt fingerprint-based drug testing technology to support the health and safety of its employees and customers. Abellio operates day and night bus services across London, and will use the portable Intelligent Fingerprinting drug screening system to support random, for cause and post-incident drug testing for its 2,100 drivers and 200 other safety-critical employees. Alcohol testing will also take place at the same time.
Adopting the Intelligent Fingerprinting solution will enhance Abellio’s previous urine-based testing approach, which proved challenging in terms of observed sample collection, the requirement for gender-specific testing staff and specially-prepared collection areas. In contrast, fingerprint-based testing offers a non-invasive, quicker and more dignified solution to Abellio’s workplace drug testing requirements. The portability of the solution will also enable Abellio to conduct tests of its employees on location at any of its six depots in Central, South and West London.
“At Abellio we’re focused on providing better quality, safer and more convenient transport services for our clients and customers, and we see workplace drug and alcohol testing as an important part of our commitment to ensure a safe service. The Intelligent Fingerprinting system makes the drug screening process much easier, less intrusive for our staff, and also allows us to test a lot more of our employees, significantly improving our risk management processes. Following union consultation and approval of the Intelligent Fingerprinting system, we’ve now adopted it to enhance our drug and alcohol testing approach and have incorporated the process into our drug and alcohol policy.”
Read the case study: Abellio Case Study PDF